There is a critical need to improve adherence to uACR testing guidelines in US patients with type 2 diabetes to prevent delays in CKD diagnosis and treatment.
We describe the substantial shortfall in adherence to guideline-recommended albumin-to-creatinine ratio (uACR) testing for people in the United States with type 2 diabetes. Poor compliance with current guidelines leads to delays in diagnosis-and treatment- of chronic kidney disease, which adversely affects clinical outcomes and contributes to incremental economic burden.
No takes yet. Share an insight, caveat, or question.
Williamson et al. (2023) studied this question. Poor adherence to albuminuria testing guidelines in US patients with type 2 diabetes leads to delayed chronic kidney disease diagnosis, adverse clinical outcomes, and economic burden.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: